Appoint Drs. David Reardon, Timothy Cloughesy, and Nicholas Butowski VANCOUVER, British Columbia and MENLO PARK, Calif., May 20, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical… Read More
Company will host a business update conference call on May 23, 2019 at 4:30 PM Eastern Time VANCOUVER, British Columbia and MENLO PARK, Calif., May 15, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq:… Read More
WARMINSTER, Pa., May 13, 2019 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Mark J. Murray, Arbutus’ President and CEO, will present… Read More
Vancouver, Canada – Virogin Biotech (“Virogin”) is pleased to announce it has recently signed an agreement with China National Biotec Group (CNBG) to create a Joint Venture that will focus… Read More
VANCOUVER, British Columbia and MENLO PARK, Calif., May 8, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development and commercialization of new… Read More
